NTRB earnings date and last-quarter result: last quarter beat, P/E -1.16. Updated 2026-07-23.
Nutriband (NTRB) Research Hub
Nutriband (NTRB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 5.97 USD (+3.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.16, market cap 0.04B. This hub links to the full technical, earnings and options research available for NTRB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 5.97 USD (+3.65%) |
| 52-week range | 2.8 USD – 9.185 USD |
| Trend regime | Range |
| 14-day RSI | 42 (Bearish) |
| Trailing P/E | -1.16 |
| Market cap | 0.04B |
| Dividend yield | 0.00% |
Available research for NTRB
Covered Call on NTRB: how it works, illustrative setup around the real 5.97 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NTRB: how it works, illustrative setup around the real 5.97 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NTRB: how it works, illustrative setup around the real 5.97 USD price, max profit/loss, breakeven and when to use it. Educational.
NTRB technical analysis: range, last 5.97 USD, RSI 42, 52w range 2.8 USD–9.185 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NTRB in?
Nutriband (NTRB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is NTRB in an uptrend or downtrend?
As of 2026-10-26, NTRB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NTRB's trailing P/E ratio?
NTRB's trailing P/E is -1.16, with a market cap of 0.04B. See the earnings research page for full valuation detail.